Injeq visited Hong Kong as part of the Finnish HealthTech delegation. There were many interesting introductions of business opportunities in Hong Kong and in Greater Bay Area. Our CEO Timo Hänninen had a pleasure to give a presentation of the IQ-TipR system as the first digital needle solution on the market in the world class cancer treatment hospital at Hong Kong Sanatorium and Hospital Proton Therapy Centre.
Injeq’s Harri Sievänen has publish new interesting findings about the incidence of traumatic lumbar punctures. “According to binary logistic regression, […]
Read more »
Injeq IQ-Tip was introduced to Kuwaiti doctors in October. Product Line Manager Mr Ahmed Jamous from Mareen Group had a […]
Read more »
In 2023 Injeq Oyj organized a share issue between June 21 and August 28, when the company received capital investment […]
Read more »
Last week almost 60 Austrian healthcare professionals attended the matchmaking event organised by Business Finland and the Wiener Gesundheitsverbund on […]
Read more »
Injeq is happy to announce that Injeq IQ-Tip device with its indications for use meet the criteria and have been […]
Read more »
Injeq IQ-Tip system has been granted the Breakthrough Device designation by FDA! The FDA’s Breakthrough Devices Program is designed to […]
Read more »